Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M5,372Revenue $M1,302Net Margin (%)11.2Z-Score2.8
Enterprise Value $M5,852EPS $0.3Operating Margin %13.0F-Score8
P/E(ttm))39.5Cash Flow Per Share $1.7Pre-tax Margin (%)10.1Higher ROA y-yY
Price/Book2.010-y EBITDA Growth Rate %6.4Quick Ratio2.6Cash flow > EarningsY
Price/Sales4.25-y EBITDA Growth Rate %-4.2Current Ratio2.9Lower Leverage y-yN
Price/Cash Flow10.9y-y EBITDA Growth Rate %18.6ROA % (ttm)3.5Higher Current Ratio y-yY
Dividend Yield %0Insider Buy (3m)0ROE % (ttm)5.6Less Shares Outstanding y-yY
Payout Ratio %0Shares Outstanding M233ROI % (ttm)0.4Gross Margin Increase y-yY

Gurus Latest Trades with QGEN

Number of guru portfolios checked: 84. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
QGENRon Baron 2014-03-31 Sold Out $20.46 - $24.82
($22.48)
$ 23.022%Sold Out0
QGENRon Baron 2013-12-31 Reduce$20.63 - $24.65
($22.54)
$ 23.022%Reduce -49%10,200
QGENPRIMECAP Management 2013-09-30 Add0.19%$19.72 - $21.88
($20.86)
$ 23.0210%Add 60.33%17,881,461
QGENPRIMECAP Management 2013-06-30 Add0.06%$18.45 - $21.08
($19.52)
$ 23.0218%Add 22.63%11,152,875
QGENRon Baron 2013-06-30 Reduce$18.45 - $21.08
($19.52)
$ 23.0218%Reduce -45.95%20,000
QGENPRIMECAP Management 2012-09-30 Add0.06%$16.09 - $18.97
($17.62)
$ 23.0231%Add 31.89%8,579,261
QGENPRIMECAP Management 2012-06-30 Buy 0.18%$15 - $17.22
($16.24)
$ 23.0242%New holding, 6504966 sh.6,504,966
QGENRon Baron 2012-03-31 Add$14.49 - $16.76
($14.43)
$ 23.0260%Add 26.98%40,000
QGENRon Baron 2010-12-31 Add$17.02 - $19.92
($18.77)
$ 23.0223%Add 44.23%37,500
QGENRon Baron 2010-09-30 Buy $17.66 - $20.62
($18.79)
$ 23.0222%New holding, 26000 sh.26,000
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

QGEN is held by these Gurus:

Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
QGEN PRIMECAP Management 2014-09-3022,080,1149.460.54-0.03%
Premium Most recent portfolio changes are included for Premium Members only!


QGEN: Insider Buys/Sells

Click Here for All Insider Trades.

No Insider Trades Found!

Press Releases about QGEN :

    Quarterly/Annual Reports about QGEN:

      News about QGEN:

      Articles On GuruFocus.com
      comment on QGEN May 14 2013 
      comment on QGEN May 10 2013 
      Biotech Gets Personal: Long on Qiagen (QGEN) & SPDR S&P Biotech (XBI) Feb 29 2012 
      Guru Stocks at 52-Week Lows: LMT, VIP, VMC, IRM, QGEN Oct 10 2010 
      Weekly Guru Bargains Highlights: QGEN, BXS, ATHR, LYV, TFSL Oct 09 2010 

      More From Other Websites
      UMS United Medical Systems International AG: UMS United Medical Systems International AG, Hamburg... Dec 16 2014
      Press Release: 4SC reports positive topline data from clinical Phase I trial with 4SC-205 in cancer... Dec 09 2014
      QIAGEN to Distribute altona Diagnostic's RealStar® Ebolavirus RT-PCR Kit 1.0, Recently Authorized... Dec 04 2014
      Qiagen Partners with Novartis for Companion Diagnostics Nov 13 2014
      QIAGEN signs ninth master collaboration agreement for companion diagnostics Nov 11 2014
      QIAGEN Signs Ninth Master Collaboration Agreement for Companion Diagnostics Nov 11 2014
      Qiagen Q3 Earnings, Revenues in Line; Outlook Revised Oct 30 2014
      Qiagen meets 3Q profit forecasts Oct 29 2014
      Qiagen meets 3Q profit forecasts Oct 29 2014
      QIAGEN reports results for third quarter and first nine months of 2014 Oct 29 2014
      QIAGEN Reports Results for Third Quarter and First Nine Months of 2014 Oct 29 2014
      Can Qiagen (QGEN) Surprise Earnings Estimates in Q3? Oct 28 2014
      QIAGEN announces broad agreement with Astellas Pharma to develop companion diagnostics Oct 28 2014
      QIAGEN Announces Broad Agreement With Astellas Pharma to Develop Companion Diagnostics Oct 28 2014
      QIAGEN Applauds Inclusion of Screening and Treatment for Latent Infection in WHO's Post-2015 Global... Oct 28 2014
      QIAGEN demonstrates expanded bioinformatics workflows at ASHG; strong market adoption as researchers... Oct 17 2014
      QIAGEN Demonstrates Expanded Bioinformatics Workflows at ASHG; Strong Market Adoption as Researchers... Oct 17 2014
      Genomics England names QIAGEN Bioinformatics one of the UK100K project assessment winners Oct 14 2014
      Genomics England Names QIAGEN Bioinformatics One of the UK100K Project Assessment Winners Oct 14 2014
      Genomics England Names QIAGEN Bioinformatics One of the UK100K Project Assessment Winners Oct 14 2014

      Add Notes, Comments

      If you want to ask a question, or report a bug, please create a support ticket.

      User Comments

      No comment yet
      Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
      GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
      Free 7-day Trial
      FEEDBACK